BCAT2 and non-small cell lung carcinoma: Interestingly, we did not observe markedly upregulated expression of mitochondrial BCAT2 in our resistant cells (Supplementary Fig. 3a, b), suggesting that BCAT1 was the main BCAT enzyme isoform involved in TKI-resistant NSCLC cells.